As the lot number for the device was not provided, a manufacturing review could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.Journal article citation: bosch, c.H.V.D., bruggen, j.T.V.D., frakking, f.N., scheltinga, c.E.T.V., ven, c.P.V.D., grotel, m.V., wijnen, m.H.(2019).Incidence, severity and outcome of central line related complications in pediatric oncology patients; a single center study.Journal of pediatric surgery, 54(9), 1894¿1900.Doi: 10.1016/j.Jpedsurg.2018.10.054.(b)(4).
|
It was reported in an article from the journal of pediatric surgery titled " incidence, severity and outcome of central line related complications in pediatric oncology patients; a single center study " that pneumothorax was identified in 1 patient, other surgical complications was identified in 11 patients, which required device removal in 1 patient, hematoma was identified in 12 patients, central line-associated blood stream infections(clabsis) were identified in 64 patients, which required device removal in 34 patients, local infection was identified in 27 patients, which required device removal in 4 patients, and thrombosis was identified in 5 patients, which required device removal in 2 patients.All patients with infection were treated with systemic antibiotic therapy (sat).The status of the patients was not provided.
|